🧠 New Neuralink Competitor Secures $50M Investment

Andreessen Horowitz (a16z), a venture capital firm, has invested $50 million in Echo Neurotechnologies Corp., which is developing a brain-computer interface. This is a16z's first entry into the brain implant sector, even though Echo Neurotechnologies has yet to demonstrate a working prototype.

Neurosurgeon Edward Chang, the chairman of the neurosurgery department at the University of California at San Francisco, leads the startup. Chang led the development of an interface in 2023 that allowed a disabled woman to "speak" by analyzing her brain waves with AI.

Using this digital assistant, the patient obtained a speaking rate of 80 words per minute, comparable to the ordinary person. In contrast, her prior speech computer only let her type 14 words per minute.

Neither a16z nor Echo Neurotechnologies have disclosed further details, but the startup is actively hiring. Its website hints that the project launch is coming "soon."

The first moderately successful commercial neuroimplant project was Neuralink, which Elon Musk introduced in 2017. The company currently has three patients with implanted chips.

Before Neuralink, brain-computer interfaces were mostly the subject of academic research. However, Musk's venture has spawned competition, with companies like Paradromics and Precision Neuroscience entering the market. Some are proposing ultra-revolutionary approaches—recently, we covered the startup Science, which plans to use living neurons instead of traditional electrodes for its interface.

More on the topic:

➡️ Life of the First Neuralink Patient

➡️ A Neuralink Patient Learned to Control a Robotic Arm

#news #science #neuralink @hiaimediaen